Literature DB >> 6879015

Control of measles in Czechoslovakia (CSSR).

J Sejda.   

Abstract

Mass immunization against measles in the Czechoslovak Socialist Republic (CSSR) began in 1969 and utilized the Czechoslovak vaccine, which corresponds in its parameters to the further-attenuated measles vaccines. The immunization rate for relevant age groups of the population (i.e., children born in 1968-1980) is already 98%-99% in 1982. Measles morbidity decreased to less than 2% of the incidence before the introduction of immunization, and the mortality now is practically negligible. The decade 1972-1982 produced significant changes in epidemiologic characteristics of measles. Of importance is the gradual shift in the age distribution of affected children to older, nonimmunized age groups. Results of yearly immunologic surveys of a broad, randomly selected population sample have become the decisive criteria for evaluation of vaccine efficacy. The program of revaccination of all children was chosen as the optimal strategy for maintaining measles elimination. This program aims at ensuring a level of herd immunity in the whole population of greater than or equal to 95%.

Entities:  

Mesh:

Year:  1983        PMID: 6879015     DOI: 10.1093/clinids/5.3.564

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  New York State's two-dose schedule for measles immunization.

Authors:  G S Birkhead; D L Morse; I J Mills; L F Novick
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

2.  Seroepidemiology of measles in Catalonia (Spain) 1985-1986.

Authors:  L Salleras; J Vidal; J Canela; M T Jimenez De Anta; T Pumarola; J J Coll; M L De La Puente; L Serra
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

3.  Surveillance for the Expanded Programme on Immunization.

Authors:  F T Cutts; R J Waldman; H M Zoffman
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

4.  Scandinavian model for eliminating measles, mumps, and rubella.

Authors:  E Rabo; J Taranger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.